UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sex Hormones and Anticancer Immunity

Clinical cancer research, 2019-08, Vol.25 (15), p.4603-4610

2019

Volltextzugriff (PDF)

Removing barriers to address sex differences in anticancer drug toxicity

Nature reviews. Cancer, 2024-03, Vol.24 (3), p.161-162

Özdemir, Berna C

2024

Volltextzugriff (PDF)

Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

Journal of clinical oncology, 2018-09, Vol.36 (26), p.2680-2683

2018

Volltextzugriff (PDF)

Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors

Cancer treatment reviews, 2021-11, Vol.100, p.102282-102282, Article 102282

2021

Volltextzugriff (PDF)

Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology

Endocrinology (Philadelphia), 2022-06, Vol.163 (6), p.1

2022

Volltextzugriff (PDF)

Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology

Journal for immunotherapy of cancer, 2021-02, Vol.9 (2), p.e002220

Özdemir, Berna C

2021

Volltextzugriff (PDF)

Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease

Oncology letters, 2023-09, Vol.26 (3), p.1, Article 377

2023

Volltextzugriff (PDF)

Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

Trends in Cancer, 2017-03, Vol.3 (3), p.181-197

2017

Volltextzugriff (PDF)

The challenges of modeling hormone receptor-positive breast cancer in mice

Endocrine-related cancer, 2018-05, Vol.25 (5), p.R319-R330

2018

Volltextzugriff (PDF)

Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation

The Journal of clinical investigation, 2018-12, Vol.128 (12), p.5531-5548

2018

Volltextzugriff (PDF)

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches

PloS one, 2014-12, Vol.9 (12), p.e114530-e114530

2014

Volltextzugriff (PDF)

TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis

Journal of the American Society of Nephrology, 2013-03, Vol.24 (3), p.385-392

2013

Volltextzugriff (PDF)

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

The Journal of experimental medicine, 2021-02, Vol.218 (2)

2021

Volltextzugriff (PDF)

The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook

Pharmaceuticals (Basel, Switzerland), 2023-10, Vol.16 (10), p.1411

2023

Volltextzugriff (PDF)

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

Journal of clinical oncology, 2023-11, Vol.41 (33), p.5131-5139

2023

Volltextzugriff (PDF)

Human epidermal growth factor receptor 2-positive digestive tumors

Current opinion in oncology, 2019-07, Vol.31 (4), p.354-361

2019

Volltextzugriff (PDF)

Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine

BJU international, 2024-09, Vol.134 (3), p.388-397

2024

Volltextzugriff (PDF)

Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis

Biology (Basel, Switzerland), 2022-03, Vol.11 (3), p.422

2022

Volltextzugriff (PDF)

Androgen Signaling in the Tumor Microenvironment

Advances in experimental medicine and biology, 2021, Vol.1270, p.169-183

2021

Volltextzugriff (PDF)

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients

Cancer Immunology, Immunotherapy, 2023-07, Vol.72 (7), p.1991-2001

2023

Volltextzugriff (PDF)

Successful treatment of immune checkpoint inhibitor-related periaortitis

Swiss medical weekly, 2024-02, Vol.154 (2), p.3631

2024

Volltextzugriff (PDF)

Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry

World journal of urology, 2022-09, Vol.40 (9), p.2275-2281

2022

Volltextzugriff (PDF)

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

iScience, 2023-04, Vol.26 (4), p.106212-106212, Article 106212

2023

Volltextzugriff (PDF)

1 – 25 von 1.342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.026)
Mit Volltextzugriff
(1.006)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Sex Hormones and Anticancer Immunity

Removing barriers to address sex differences in anticancer drug toxicity

Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology

Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors

Sex and gender differences in anticancer treatment toxicity - a call for revisiting drug dosing in oncology

Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology

Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease

Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?

The challenges of modeling hormone receptor-positive breast cancer in mice

Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation

The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches

TGF-β1-Containing Exosomes from Injured Epithelial Cells Activate Fibroblasts to Initiate Tissue Regenerative Responses and Fibrosis

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis

The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook

Perioperative Chemoimmunotherapy With Durvalumab for Muscle-Invasive Urothelial Carcinoma: Primary Analysis of the Single-Arm Phase II Trial SAKK 06/17

Human epidermal growth factor receptor 2-positive digestive tumors

Safety and quality of cystectomy and pelvic lymph node dissection after neoadjuvant durvalumab and cisplatin/gemcitabine

Prescription Patterns, Recurrence, and Toxicity Rates of Adjuvant Treatment for Stage III/IV Melanoma-A Real World Single-Center Analysis

Androgen Signaling in the Tumor Microenvironment

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients

Successful treatment of immune checkpoint inhibitor-related periaortitis

Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research

Suchergebnisse filtern